Rich Recovery Cream Base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin serves as the polyol humectant in these cosmetic formats, while the stated percentage remains a formulation reference.

3. Typical use levels (formulation guide)

• 3–8% is listed for gels and serums in this reference.
• The guide range for creams is 2–5% in this reference.
• The stated reference for rinse-off is 2–4% in this reference.

Incorporate Glycerin in the water phase without a separate melt step.

4. Regulatory sources & global compliance

• CosIng provides reference information for Glycerin; confirm the specific grade and intended use against market requirements.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Glycerin as it will be marketed for the specific product as it will be marketed.
• Verify the purchased Glycerin grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; no drug approval or OTC status is conferred by this entry with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; if oxidation risk calls for it, review a pump or airless format; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• This guide frames Glycerin's cosmetic direction around humectant function.

• The ingredient guidance cannot substantiate medical outcomes, cure language, or a product certification not supported by the available facts.
• The cosmetic guidance for Glycerin does not confirm skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• 2–6% is listed for gel-creams as a formulation guide.
• For dry oils, the reference gives 10–30%.
• For balms, use 5–15%.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• If Squalane appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require a safety assessment of the complete cosmetic formula containing Squalane for the product in its final form.
• Use current supplier documentation for the purchased Squalane grade and verify applicable destination-market filings.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; this reference is not approval for drug use or OTC marketing and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; evaluate packaging against the formula's susceptibility to oxidation; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• The available ingredient details is not evidence of therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The Squalane entry does not substantiate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The butter role is assigned to shea in creams, balms, and hair creams. The reference makes no assumption about unrefined color or scent.

3. Typical use levels (formulation guide)

• The creams use-level reference is 2–8% for the formula.
• Balms and butters may use the guide range 10–25% in this reference.

To reduce graininess, melt Butyrospermum Parkii Butter into the oil phase and maintain shear while it cools.

4. Regulatory sources & global compliance

• The CosIng record for Butyrospermum Parkii Butter, where listed, is informational rather than product-specific authorization.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Butyrospermum Parkii Butter before release of the finished cosmetic.
• Check the supplier's technical information for the Butyrospermum Parkii Butter grade and confirm the relevant market filing list.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; it makes no claim of drug or OTC authorization so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Protect the sealed bulk from heat, sun, and unnecessary exposure; where oxidation is a concern, evaluate airless or pump packaging; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Butyrospermum Parkii Butter centers on shea cushion.

• The ingredient guidance cannot substantiate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• This cosmetic entry naming Butyrospermum Parkii Butter should not be used to substantiate whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.